Blueprint Medicines
BPMC
#2435
Rank
C$8.46 B
Marketcap
$133.22
Share price
-1.31%
Change (1 day)
12.98%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$12.39

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$13.03. In 2022 the company made an earnings per share (EPS) of -$13.26 an increase over its 2021 EPS that were of -$15.57.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.39-6.52%
2022-$13.26-14.85%
2021-$15.57-297.13%
2020$7.90-176.3%
2019-$10.3535.19%
2018-$7.6638.82%
2017-$5.5247.35%
2016-$3.749.25%
2015-$3.43-31.35%
2014-$4.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.09927-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.38-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.80-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA